U.S. Uterine Fibroid Market Information by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022
Pune, India -- (SBWIRE) -- 07/14/2017 -- Market Synopsis of U.S. Uterine Fibroid Market:
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman's uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.
The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.
Key Players for U.S. Uterine Fibroid Market:
- AstraZeneca (England),
- Cook Medical Inc. (US),
- Boston Scientific Corporation (US),
- GE Healthcare (U.K.),
- AbbVie Inc. (U.S.),
- Hologic (U.S.),
Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2394
Regional Analysis of U.S. Uterine Fibroid Market:
The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Uterine Fibroid Market Research Report - U.S. Forecast to 2022"
Browse full report @ https://www.marketresearchfuture.com/reports/uterine-fibroid-market
Table of Content
1 Introduction 8
1.1.1 Prevalence of the Uterine Fibroids in U.S. 8
2 Scope of Study 10
2.1 Research Objective 10
2.2 Assumptions & Limitations 10
2.2.1 Assumptions 10
2.2.2 Limitations 10
2.3 Market Structure 11
3 Research Methodology 12
3.1 Primary Research 13
3.2 Secondary Research 13
4 U.S. Uterine Fibroid Market 15
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21
5 Company Profile 29
Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312